Your browser doesn't support javascript.
loading
Image guided dilation of sinus ostium in revision sinus surgery.
Han, Joseph K; Palmer, James N; Adappa, Nithin D; Nachlas, Nathan E; Chandra, Rakesh K; Jacobs, Joseph B; Manes, R Peter; McKenzie, Karen.
Afiliação
  • Han JK; Eastern Virginia Medical School, Norfolk, VA, USA. Electronic address: hanjk@evms.edu.
  • Palmer JN; University of Pennsylvania, Philadelphia, PA, USA.
  • Adappa ND; University of Pennsylvania, Philadelphia, PA, USA.
  • Nachlas NE; ENT and Allergy Associates of Florida, Boca Raton, FL, USA.
  • Chandra RK; Vanderbilt University, Nashville, TN, USA.
  • Jacobs JB; New York University Medical Center (NYU), New York, NY, USA.
  • Manes RP; Yale University, New Haven, CT, USA.
  • McKenzie K; Medtronic Xomed, Inc., Jacksonville, FL, USA.
Am J Otolaryngol ; 44(3): 103803, 2023.
Article em En | MEDLINE | ID: mdl-36889144
ABSTRACT

PURPOSE:

Assess if a rigid, image-guided balloon could be used effectively and safely in revision sinus surgery. MATERIALS AND

METHODS:

A prospective, non-randomized, single-arm, multicenter study to assess the safety and device performance of the NuVent™ EM Balloon Sinus Dilation System. Adults with CRS in need of revision sinus surgery were enrolled for balloon sinus dilation of a frontal, sphenoid, or maxillary sinus. The primary device performance endpoint was the ability of the device to (1) navigate to; and (2) dilate tissue in subjects with scarred, granulated, or previously surgically-altered tissue (revision). Safety outcomes included the assessment of any operative adverse events (AEs) directly attributable to the device or for which direct cause could not be determined. A follow-up endoscopy was conducted at 14 days post-treatment for assessment of any AEs. Performance outcomes included the surgeon's ability to reach the target sinus (es) and dilate the ostia. Endoscopic photos were captured for each treated sinus pre- and post-dilation.

RESULTS:

At 6 US clinical sites, 51 subjects were enrolled; 1 subject withdrew before treatment due to a cardiac complication from anesthesia. 121 sinuses were treated in 50 subjects. The device performed as expected in 100 % of the 121 treated sinuses, with investigators able to navigate to the treatment area and dilate the sinus ostium without difficulty. Ten AEs were seen in 9 subjects, with 0 related to the device.

CONCLUSION:

The targeted frontal, maxillary or sphenoid sinus ostium were safely dilated in every revision subject treated, with no AEs directly attributed to the device.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article